Newport Beach, CA, United States of America

Swarnendra K Verma

This inventor holds 1 USPTO granted patent. Top assignee: Horizon Therapeutics USA, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Swarnendra K Verma. Retrieved from https://idiyas.com/inventor/swarnendra-k-verma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Swarnendra K. Verma and His Work on Gout Treatment

Introduction

Swarnendra K. Verma is an inventor based in Newport Beach, California, and is associated with Horizon Therapeutics USA, Inc. His patent work addresses treatment approaches for gout using PEGylated uricase.

Latest Patents

Verma is named on one patent, “Methods of Treating Gout.” The disclosure describes administering PEGylated uricase through an infusion lasting less than 120 minutes and using an infusion volume below 250 mL. It also describes co-administering PEGylated uricase with methotrexate (MTX), including approaches intended to reduce immunogenicity and prolong the urate-lowering effect. Verma’s listed portfolio includes 1 patent.

Career Highlights

Verma’s identified patent contribution focuses on potential ways to make PEGylated uricase treatment more practical and to support its therapeutic effects. His work is associated with Horizon Therapeutics USA, Inc.

Collaborations

Verma’s listed coworker is Paul Michael Peloso. The patent disclosure also describes co-administration of PEGylated uricase and MTX as part of its proposed treatment approaches.

Conclusion

Swarnendra K. Verma’s patent work centers on infusion protocols and combination treatment strategies for gout, reflecting an innovation focus on PEGylated uricase therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…